With a capex of Rs 75 crore, Thyrocare Technologies‘ CEO A Velumani is confident of increasing its reach with 25 laboratories in the coming year. He expects the company to clock a CAGR of 25-35% in the next few years.
first published: May 9, 2016 11:29 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

